Japanese Market for Interventional Cardiology 2010

Friday, April 30, 2010 Heart Disease News J E 4
Japanese Market for Interventional Cardiology 2010 In 2009 the Japanese market for interventional cardiology devices was valued at nearly $1.2 billion. Japan has one of the oldest populations in the world and demographic pressure is increasing the demand for healthcare. As a result the Japanese government is attempting to reduce costs by decreasing reimbursement rates thus putting downward pressure on prices and limiting growth of the market for interventional cardiology devices. Meanwhile the high use of intravascular imaging in Japan makes the country a model for how global interventional cardiology markets may respond to the increasing utilization of IVUS and OCT. ( ) The Japanese market for interventional cardiology devices includes the markets for: * Coronary stents * Percutaneous transluminal coronary angioplasty (PTCA) balloon catheters * Interventional catheters * Interventional guidewires * Introducer sheaths * Embolic protection devices (EPD) * Atherectomy devices * Thrombectomy devices * Diagnostic catheters * Intravascular ultrasound (IVUS) catheters * Optical coherence tomography (OCT) catheters Within the Japanese interventional cardiology device market companies such as Abbott Laboratories Asahi Intecc Boston Scientific Cordis Medtronic and Terumo lead the market. This report provides a comprehensive and detailed analysis of market revenues by device type market forecasts through 2016 unit sales average selling prices market drivers and limiters and a detailed competitive analysis including manufacturer market shares and product portfolios. To know more and to buy a copy of your report feel free to visit : Or Contact us at : Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: Website: Follow us on twitter:


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
BELLUS Health and Celtic Therapeutics enter agreem...
Ortho-McNeil-Janssen Pharmaceuticals, Inc. Agrees ...